ProPhase Labs to Present at the H.C. Wainwright Bioconnect 2022 Virtual Conference
05 janv. 2022 08h30 HE
|
ProPhase Labs, Inc.
GARDEN CITY, NY, Jan. 05, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified biotech and genomics company, announces today that Chairman and CEO Ted Karkus will present a...
ObsEva to Present at the H.C. Wainwright BioConnect 2022 Conference
03 janv. 2022 07h00 HE
|
ObsEva SA
GENEVA, Switzerland January 3, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, today...
ObsEva to Present at the H.C. Wainwright BioConnect 2022 Conference
03 janv. 2022 01h00 HE
|
ObsEva SA
GENEVA, Switzerland January 3, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, today...